Skip to content

fMRI study on the timing of rTMS intervention in the inferior parietal lobule and the plasticity mechanism of frontoparietal network in stroke patients with hemiplegia

fMRI study on the timing of rTMS intervention in the inferior parietal lobule and the plasticity mechanism of frontoparietal network in stroke patients with hemiplegia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078368
Enrollment
Unknown
Registered
2023-12-06
Start date
2024-01-01
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

high frequency rTMS:high frequency rTMS on iIPL
sham rTMS:sham rTMS on cM1

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) first-ever stroke (2) diagnosed by computed tomography or MRI as subcortical ischemic or hemorrhagic stroke (3) clear consciousness and stable vital signs (4) age between 18 and 80 years, regardless of gender (5) between 2 weeks to 6 months following stroke onset (6) unilateral upper limb and hand hemiplegia (Modified Brunnstrom classification as grade I-IV) (7) right handed according to the Edinburgh Handedness Inventory (8) voluntarily sign an informed consent form and are willing to participate in this study Healthy subjects (1) 18-80 years old, regardless of gender; (2) Right handedness; (3) Voluntary signing of informed consent form;

Exclusion criteria

Exclusion criteria: (1) severe speech, attention, hearing, visual, sensory, intellectual, mental, or cognitive impairments (MMSE 2) of the affected upper extremity or significant pain on the affected side (Ten-point Visual Analog Scale > 4) (3) osteoarthritis or other serious neurological disorders (4) from other cities and unable to be followed up (5) alcohol or drug addiction (6) malignant tumors (7) severe cardiovascular diseases such as heart failure, severe respiratory diseases such as lung infections, severe liver diseases such as ALT>2 times the upper limit of normal, kidney diseases such as creatinine>the upper limit of normal, and other unstable clinical symptoms (8) epilepsy (9) contraindications to rTMS such as metal implant, magnetic sheet or cardiac pacemaker (10) still enrolled in any rehabilitation or drug studies (11) pregnancy Healthy subjects (1) Have any history of serious physical or brain diseases in the past; (2) Simultaneously participating in other relevant clinical researchers; (3) Pregnant women.

Design outcomes

Primary

MeasureTime frame
FM-UL;ARAT;WMFT;BI;MEP;

Secondary

MeasureTime frame
NIHSS;Brunnstrom;MMT;fMRI assessment;

Countries

China

Contacts

Public ContactLimin Sun

Huashan Hospital, Fudan University

tracy611@sina.com+86 136 1168 9182

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026